BORMANN-KENNEDY BARBARA-JEAN ANNE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-06-05	2026-06-04	Xeris Biopharma Holdings Inc (XERS)	PlS Planned sale	51,627 -12.5% 173.38 US$1,714,597	51,627 -12.5%	173.38	US$1,714,597
2026-06-04	2026-06-04	Xeris Biopharma Holdings Inc (XERS)	PrS Proposed sale	7,210 80.81 US$2,770,123	7,210	80.81	US$2,770,123
2025-12-15	2025-12-12	Xeris Biopharma Holdings Inc (XERS)	PlS Planned sale	64,428 -21.3% 182.12 US$2,264,951	64,428 -21.3%	182.12	US$2,264,951
2025-12-12	2025-12-12	Xeris Biopharma Holdings Inc (XERS)	PrS Proposed sale	15,000 7.01 US$105,150	15,000	7.01	US$105,150